Testosterone Cypionate Dosage, Injection and Cycles

    Testosterone cypionate dosage from the vial: 200 mg/mL math, label and guideline regimens, intramuscular and subcutaneous technique, storage, and what a cycle is.

    Testosterone cypionate dosage comes down to three numbers: the strength on the vial (100 or 200 mg/mL), the dose in milligrams, and the interval. Everything else, the syringe, the needle, the site and the schedule, follows from those.

    This page covers the arithmetic, the intramuscular technique the label describes, the subcutaneous technique clinics use off-label, storage, and then the non-medical "cycle" schedules users describe. The medical dose ranges come from the Depo-Testosterone and Azmiro labels and the Endocrine Society guideline; the cycle doses are user reports, labeled as such.

    Key takeaway
    200 mg/mL means 0.5 mL for 100 mg and 1 mL for 200 mg; the label says deep gluteal intramuscular injection, 50 to 400 mg every two to four weeks; the guideline says 75 to 100 mg weekly or 150 to 200 mg every two weeks; store at room temperature away from light. A "cycle" is a non-medical schedule at several times those doses and is not something the label supports.

    Reading the Vial

    Dose to volume at the two approved strengths

    Dose
    Volume at 100 mg/mL
    Volume at 200 mg/mL

    50 mg

    0.5 mL

    0.25 mL

    100 mg

    1.0 mL

    0.5 mL

    150 mg

    1.5 mL

    0.75 mL

    200 mg

    2.0 mL

    1.0 mL

    What is on the market:

    1. 1Depo-Testosterone: 100 mg/mL in 10 mL vials; 200 mg/mL in 1 mL and 10 mL vials
    2. 2Generics: mostly 200 mg/mL in 1 mL and 10 mL
    3. 3Azmiro: 200 mg/mL single-dose vial and a 200 mg prefilled syringe

    The labels warn that injectable testosterone products are not substitutable milligram for milligram, and that cypionate should not be swapped with propionate because the durations differ. A 10 mL vial on a 100 mg weekly schedule is 20 doses, about five months.


    Dose and Interval

    Regimens by source

    Source
    Dose and interval
    Notes

    Depo-Testosterone label

    50 to 400 mg every 2 to 4 weeks

    Adjusted to response and side effects; intramuscular only

    Endocrine Society (2018)

    75 to 100 mg weekly or 150 to 200 mg every 2 weeks

    Target mid-normal testosterone measured mid-interval

    Common clinic practice

    40 to 60 mg twice weekly, or 50 to 100 mg weekly subcutaneous

    Off-label schedule; flattest blood levels

    The reason for the shift toward smaller, more frequent doses is the eight-day half-life. After a single 200 mg injection, testosterone peaked at a mean 758 ng/dL about 72 hours later in the Azmiro study and then fell steadily; by day 14 a man is near where he started.

    250500750100007142128peak 758 ng/dL at about 72 hhalf of the peak rise by day 11Days after one 200 mg injection (schematic from the label: 8-day half-life)

    Splitting the same 200 mg into two weekly 100 mg doses roughly halves the swing, and twice-weekly dosing flattens it further. The diagnosis, targets and monitoring that go with these numbers are in the TRT guide.


    Intramuscular Technique

    The label says deep gluteal intramuscular injection, never intravenous. Clinics teach the ventrogluteal site (the hip, located with the heel of the hand on the greater trochanter) or the upper outer quadrant of the buttock; many patients self-inject into the outer thigh or deltoid for smaller volumes.

    A typical setup:

    1. 118 to 21 gauge needle to draw, because cottonseed oil is thick
    2. 223 to 25 gauge, 1 to 1.5 inch needle to inject
    3. 3Alcohol swab for the vial stopper and the skin

    The steps:

    1. 1Swab the stopper, draw the dose slowly, swap to the injection needle, expel air.
    2. 2Swab the site, insert at 90 degrees.
    3. 3Inject over 10 to 30 seconds, withdraw, press with gauze.
    4. 4Rotate sites to prevent scarring and lumps.
    A brief cough or chest tightness right after injecting is a sign of oil reaching a vein and is why the slow, steady technique matters.

    Subcutaneous Technique

    The label does not describe subcutaneous injection; clinics do, and the published results support it.

    A 2017 academic clinic cohort, 63 patients on weekly subcutaneous cypionate or enanthate:

    1. 1Doses 50 to 150 mg, median 75 to 80 mg
    2. 2Every patient reached the normal male testosterone range
    3. 3Nine had minor, transient local reactions
    4. 4All 22 who had switched from intramuscular injections preferred subcutaneous

    The FDA-approved subcutaneous product is Xyosted (testosterone enanthate in an autoinjector, 50, 75 or 100 mg weekly into the abdomen), which is the precedent prescribers cite.

    The technique: an insulin-type syringe (27 to 30 gauge, half inch), a pinched fold of abdominal or thigh fat, 0.25 to 0.5 mL per site, and the same rotation. Because it is off-label, a prescriber's agreement and the usual blood work are the condition.


    Storage and Handling

    1. 1Temperature: 20 to 25 °C (68 to 77 °F); Azmiro allows 15 to 25 °C with excursions to 2 to 30 °C
    2. 2Light: keep in the carton
    3. 3Refrigeration: no; cold makes the oil cloudy and can crystallize the ester, and the label says warming and shaking redissolves crystals
    4. 4Multi-dose vial: fresh sterile needle each entry; the benzyl alcohol preservative is what makes repeated entry acceptable
    5. 5Discard: a vial that stays cloudy at room temperature, shows particles or changes color
    6. 6Sharps: used needles in a sharps container
    7. 7Travel: prescription label on the vial; documentation across borders, since testosterone is Schedule III

    Cycles: What Users Describe

    A "cycle" in bodybuilding use is a period of weeks at a dose several times the replacement range, followed by a break or a "post-cycle" period.

    Forum reports, not protocols:

    1. 1First testosterone-only cycle: 300 to 500 mg a week for 10 to 16 weeks, split into two injections
    2. 2Later cycles: higher, or stacked with other steroids
    3. 3"Blast and cruise": alternating those doses with a replacement-level dose instead of stopping

    The label's Drug Abuse and Dependence section is written about exactly these doses. It lists cardiac arrest, myocardial infarction, hypertrophic cardiomyopathy, heart failure, stroke, hepatotoxicity, major depression, mania, paranoia and psychosis among the reactions reported with abuse, plus testicular atrophy, infertility and withdrawal symptoms lasting weeks or months. The measurable part, hematocrit, blood pressure, lipids and estradiol, is set against the trials on the bodybuilding page.


    Missed Doses and Switching

    1. 1Missed weekly injection: take it when remembered and continue; with an eight-day half-life a few days' delay lowers the trough but does not reset anything
    2. 2Doubling to catch up: raises the peak and the estrogen and hematocrit effects with it; do not
    3. 3Two-week to weekly: halve the dose, not keep it
    4. 4Cypionate to enanthate: common, treated as equivalent in practice, though the labels say injectables are not substitutable milligram for milligram
    5. 5To or from gel, pellets or oral undecanoate: a prescriber's conversion, not a calculation from the vial

    Frequently Asked Questions

    At 200 mg/mL, 1 mL is 200 mg; at 100 mg/mL it is 100 mg. Half a mL of the 200 mg/mL strength is a common weekly 100 mg dose.

    The Endocrine Society regimen is 75 to 100 mg weekly or 150 to 200 mg every two weeks, adjusted to mid-normal blood levels. The label range is 50 to 400 mg every two to four weeks.

    The label says deep in the gluteal muscle. Clinics also use the outer thigh and, off-label, subcutaneous injection into abdominal fat with an insulin syringe.

    No. Store at room temperature, 20 to 25 °C, away from light; cold can crystallize it, and warming redissolves the crystals.

    Typically an 18 to 21 gauge needle to draw and a 23 to 25 gauge, 1 to 1.5 inch needle to inject intramuscularly; 27 to 30 gauge half-inch for subcutaneous.

    A non-medical schedule, usually 300 to 500 mg a week for 10 to 16 weeks by user reports, several times the replacement dose. The label lists the serious cardiovascular and psychiatric reactions reported at those doses.

    Cypionat.com is an independent educational resource. We are not affiliated with Pfizer, Azurity, Antares or any manufacturer, pharmacy or clinic. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.

    Advertising